First Horizon Advisors, Inc. Crispr Therapeutics Ag Transaction History

First Horizon Advisors, Inc.

$3.55 Billion
Q4 2024

A detailed history of First Horizon Advisors, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 2,039 shares of CRSP stock, worth $86,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,039

Previous 1,528 33.44%

Holding current value

$86,086

Previous $71,000 12.68%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$38.65 - $55.15 $19,750 - $28,181	511 Added 33.44%	2,039 $80,000
Q3 2024 Nov 08, 2024	SELL	$44.62 - $62.75 $1,963 - $2,761	-44 Reduced 2.8%	1,528 $71,000
Q2 2024 Jul 19, 2024	BUY	$51.17 - $68.18 $6,959 - $9,272	136 Added 9.47%	1,572 $84,000
Q1 2024 Apr 26, 2024	BUY	$60.67 - $89.12 $485 - $712	8 Added 0.56%	1,436 $97,000
Q4 2023 Feb 06, 2024	SELL	$38.62 - $72.18 $4,904 - $9,166	-127 Reduced 8.17%	1,428 $89,000
Q3 2023 Oct 27, 2023	SELL	$45.39 - $59.0 $24,601 - $31,978	-542 Reduced 25.85%	1,555 $70,000
Q2 2023 Aug 03, 2023	SELL	$43.47 - $67.77 $24,951 - $38,899	-574 Reduced 21.49%	2,097 $117,000
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $21,033 - $28,789	513 Added 23.77%	2,671 $120,000
Q4 2022 Feb 10, 2023	SELL	$39.19 - $65.67 $11,247 - $18,847	-287 Reduced 11.74%	2,158 $87,000
Q3 2022 Nov 09, 2022	SELL	$61.1 - $83.78 $33,177 - $45,492	-543 Reduced 18.17%	2,445 $159,000
Q2 2022 Aug 02, 2022	BUY	$43.23 - $73.83 $129,171 - $220,604	2,988 New	2,988 $181,000
Q1 2022 May 10, 2022	SELL	$53.19 - $79.24 $52,445 - $78,130	-986 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$70.09 - $111.29 $13,317 - $21,145	190 Added 23.87%	986 $74,000
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $53,887 - $76,596	489 Added 159.28%	796 $89,000
Q3 2021 Nov 09, 2021	SELL	$110.2 - $156.64 $30,194 - $42,919	-274 Reduced 47.16%	307 $34,000
Q2 2021 Aug 09, 2021	BUY	$100.84 - $161.89 $16,033 - $25,740	159 Added 37.68%	581 $94,000
Q1 2021 May 11, 2021	BUY	$110.72 - $210.04 $46,723 - $88,636	422 New	422 $51,000

Others Institutions Holding CRSP

# of Institutions

486

Shares Held

58.9M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.29B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Crispr Therapeutics Ag Transaction History